BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15061261)

  • 21. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.
    Higashi K; Ito K; Hiramatsu Y; Ishikawa T; Sakuma T; Matsunari I; Kuga G; Miura K; Higuchi T; Tonami H; Yamamoto I
    J Nucl Med; 2005 Feb; 46(2):267-73. PubMed ID: 15695786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using(68)Ga-DOTATOC PET and comparison with (18)F-FDG PET.
    Dimitrakopoulou-Strauss A; Georgoulias V; Eisenhut M; Herth F; Koukouraki S; Mäcke HR; Haberkorn U; Strauss LG
    Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):823-30. PubMed ID: 16570185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imaging.
    Tian M; Zhang H; Higuchi T; Oriuchi N; Nakasone Y; Takata K; Nakajima N; Mogi K; Endo K
    Ann Nucl Med; 2005 Jun; 19(4):335-8. PubMed ID: 16097646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 11C-acetate PET imaging of lung cancer: comparison with 18F-FDG PET and 99mTc-MIBI SPET.
    Higashi K; Ueda Y; Matsunari I; Kodama Y; Ikeda R; Miura K; Taki S; Higuchi T; Tonami H; Yamamoto I
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):13-21. PubMed ID: 14574513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.
    Higashi K; Ueda Y; Arisaka Y; Sakuma T; Nambu Y; Oguchi M; Seki H; Taki S; Tonami H; Yamamoto I
    J Nucl Med; 2002 Jan; 43(1):39-45. PubMed ID: 11801701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the P-glycoprotein expression by 99mTc-MIBI bone marrow imaging in patients with untreated leukaemia.
    Ak I; Aslan V; Vardareli E; Gülbaş Z
    Nucl Med Commun; 2003 Apr; 24(4):397-402. PubMed ID: 12673168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
    Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
    J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical usefulness of the fluorodeoxyglucose (FDG)-PET maximal standardized uptake value (SUV) in combination with CT features for the differentiation of adenocarcinoma with a bronchioloalveolar carcinoma from other subtypes of non-small cell lung cancers.
    Sun JS; Park KJ; Sheen SS; Yoon JK; Yoon SN; Lee KB; Hwang SC
    Lung Cancer; 2009 Nov; 66(2):205-10. PubMed ID: 19203812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18)F-FDG PET results in lung cancer staging.
    Chung JH; Cho KJ; Lee SS; Baek HJ; Park JH; Cheon GJ; Choi CW; Lim SM
    J Nucl Med; 2004 Jun; 45(6):999-1003. PubMed ID: 15181136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the Glut expression related to FDG uptake in PET/CT of non-small cell lung cancer patients?
    Choi WH; Yoo IeR; O JH; Kim TJ; Lee KY; Kim YK
    Technol Health Care; 2015; 23 Suppl 2():S311-8. PubMed ID: 26410497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
    Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA
    Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discrepant uptake between fluorine-18 fluorodeoxy glucose and Tc-99m sestamibi in bronchioloalveolar cell carcinoma.
    Higuchi T; Tagawa S; Yoshida N; Araki T; Tsuchiya T; Higashi K; Taki J; Kinuya S; Nakajima K; Ikeda M; Namura M; Tonami N
    Ann Nucl Med; 2003 Sep; 17(6):499-501. PubMed ID: 14575387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of Tc-99m-tetrofosmin scintigraphy in the assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors.
    Yapar Z; Kibar M; Yapar AF; Uguz A; Ozbarlas S; Gonlusen G
    Ann Nucl Med; 2003 Sep; 17(6):443-9. PubMed ID: 14575377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of technetium-99m tetrofosmin liver imaging to detect hepatocellular carcinoma and related to expression of P-glycoprotein or multidrug resistance associated protein-a preliminary report.
    Ding HJ; Huang WT; Tsai CS; Chang CS; Kao A
    Nucl Med Biol; 2003 Jul; 30(5):471-5. PubMed ID: 12831984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.
    Buck AK; Halter G; Schirrmeister H; Kotzerke J; Wurziger I; Glatting G; Mattfeldt T; Neumaier B; Reske SN; Hetzel M
    J Nucl Med; 2003 Sep; 44(9):1426-31. PubMed ID: 12960187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer.
    Brown RS; Leung JY; Kison PV; Zasadny KR; Flint A; Wahl RL
    J Nucl Med; 1999 Apr; 40(4):556-65. PubMed ID: 10210213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correlation between SUV of (18)F-FDG PET-CT and the expression of GLUT1, MVD and Ki67 in non-small cell lung cancer].
    Duan Y; Yu LJ; Lu PO; Wang WZ
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):764-7. PubMed ID: 19173807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET.
    Cherk MH; Foo SS; Poon AM; Knight SR; Murone C; Papenfuss AT; Sachinidis JI; Saunder TH; O'Keefe GJ; Scott AM
    J Nucl Med; 2006 Dec; 47(12):1921-6. PubMed ID: 17138734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer.
    Thureau S; Chaumet-Riffaud P; Modzelewski R; Fernandez P; Tessonnier L; Vervueren L; Cachin F; Berriolo-Riedinger A; Olivier P; Kolesnikov-Gauthier H; Blagosklonov O; Bridji B; Devillers A; Collombier L; Courbon F; Gremillet E; Houzard C; Caignon JM; Roux J; Aide N; Brenot-Rossi I; Doyeux K; Dubray B; Vera P
    J Nucl Med; 2013 Sep; 54(9):1543-50. PubMed ID: 23918733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 99mTc tetrofosmin scintigraphy in acute leukaemia: the relationship between marrow uptake of tetrofosmin and P-glycoprotein and chemotherapy response.
    Sükan A; Yapar Z; SAhin B; Kara O; Fuat Yapar A; CEtiner S; Kibar M
    Nucl Med Commun; 2004 Aug; 25(8):777-85. PubMed ID: 15266171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.